Selenz, C.; Compes, A.; Nill, M.; Borchmann, S.; Odenthal, M.; Florin, A.; Brägelmann, J.; Büttner, R.; Meder, L.; Ullrich, R.T.
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer. Cancers 2022, 14, 3943.
https://doi.org/10.3390/cancers14163943
AMA Style
Selenz C, Compes A, Nill M, Borchmann S, Odenthal M, Florin A, Brägelmann J, Büttner R, Meder L, Ullrich RT.
EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer. Cancers. 2022; 14(16):3943.
https://doi.org/10.3390/cancers14163943
Chicago/Turabian Style
Selenz, Carolin, Anik Compes, Marieke Nill, Sven Borchmann, Margarete Odenthal, Alexandra Florin, Johannes Brägelmann, Reinhard Büttner, Lydia Meder, and Roland T. Ullrich.
2022. "EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer" Cancers 14, no. 16: 3943.
https://doi.org/10.3390/cancers14163943
APA Style
Selenz, C., Compes, A., Nill, M., Borchmann, S., Odenthal, M., Florin, A., Brägelmann, J., Büttner, R., Meder, L., & Ullrich, R. T.
(2022). EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer. Cancers, 14(16), 3943.
https://doi.org/10.3390/cancers14163943